Meghmani Organics Limited (MOL) Earnings Call Transcript & Summary
July 30, 2026
Earnings Call Speaker Segments
Operator
operatorLadies and gentlemen, good day, and welcome to Meghmani Organics Limited Q1 FY '27 Conference Call. [Operator Instructions] Please note that this conference is being recorded. I now hand the conference over to Ms. [ Rashmi Goel ] from Arihant Capital Markets. Thank you, and over to you, ma'am.
Unknown Attendee
attendeeHello?
Operator
operatorYour voice is not audible, ma'am?
Unknown Attendee
attendee[Technical Difficulty] On behalf of Arihant Capital Markets Limited, I, Rashmi Goel, thank you all for joining...
Operator
operatorSorry to interrupt Ms. Rashmi. Your voice is not audible.
Unknown Attendee
attendeeAm I audible?
Operator
operatorYes, ma'am. Please go ahead.
Unknown Attendee
attendeeHello, and good morning to everyone. On behalf of Arihant Capital Markets Limited, I, Rashmi Goel, thank you all for joining in to the Q1 FY '27 Earnings Conference Call of Meghmani Organics Limited. Today, from the management, we have Mr. Ankit Patel [Technical Difficulty]
Operator
operatorSorry, ma'am. You're not audible. So can the management speak. So now I hand the conference over to the management. Thank you, and over to you, sir.
Ankit Patel
executiveThank you, Rashmiji. Good evening, everyone, and thank you for joining us on our quarter 1 FY '27 earnings call. I believe you have got a chance to go through the financial results and investor presentation uploaded on the stock exchanges and the website. During the quarter, we operated in a challenging business environment, where we saw softer demand across key export markets and domestic market as well. Hello?
Operator
operatorYes, sir, please go ahead.
Ankit Patel
executiveCustomers buying behavior remained cautious due to continued macroeconomic uncertainties, resulting in a subdued offtake in both the segments. This in turn affected our capacity utilization and overall revenue performance during the quarter. While the demand environment remained soft, we remain focused on optimizing our product mix, executing disciplined pricing strategies and driving operational efficiencies across our manufacturing facilities. Pursuing this disciplined approach, we were able to achieve and deliver a healthy improvement in profitability. On a stand-alone basis, in quarter 1 FY '27, revenue stood at nearly INR 523 crores, which is down by 12% Y-o-Y. Net profit for the quarter grew by 42% Y-o-Y to nearly INR 58 crores, and our EBITDA grew by 16% on Y-o-Y basis to INR 94 crores approximately. If we talk about the revenue mix in quarter 1 FY '27, Crop Protection segment constitutes about 75% of the total revenue, while the balance 25% was from the Pigment segment. Now let us look at the segment-wise performance. In Crop Protection segment, the production stood at about 8,880 metric tons and the capacity utilization for this segment stood at nearly 63%. Revenue and EBITDA stood at INR 391 crores and INR 77.8 crores, respectively. EBITDA margin for the segment was 19.9%. For Pigment segment, production stood at 3,233 metric tons and the capacity utilization for the segment stood at 39%. The segment reported revenue of -- revenue and EBITDA of INR 131 crores and INR 15.9 crores, respectively. EBITDA margin for the segment was nearly 12.1%. Moving to our Crop Nutrition segment. The segment delivered a positive contribution to both revenue and profitability during the quarter. We have further strengthened our product -- our offering with the newly introduced Nano fertilizer products like Nano DAP, Nano NPK and Nano Zinc. This product complements our existing product portfolio and position as well as to participate in the growing adoption of next-generation Crop Nutrition solutions. We remain optimistic about the long-term growth prospects of this business and expect the positive momentum to continue over the coming quarters. In titanium dioxide, as communicated earlier, operation remains suspended due to commercial unviability arising from the elevated raw material cost and the weaker price realization following the withdrawal of antidumping duty. As we have described earlier, one of the key raw material, which is based -- which is sulfuric acid, which is based on the sulfur because of the macroeconomic factor, the prices of the raw material has increased tremendously, which is impacting the overall cost of the product and making it unviable. Because of this factor, for the time being, the operation remains suspended. If we look at our financial performance on a consolidated basis in quarter 1 FY '27, revenue stood at nearly INR 542 crores, which is down by about 12% and the net profit grew by 280% on a year-on-year basis to INR 48.2 crores and our EBITDA grew by 46% on Y-o-Y basis to nearly INR 97.9 crores. EBITDA margin on a consolidated basis stood at 18% as compared to 10.9% in the corresponding quarter previous year. As of 30th June 2026, on a stand-alone basis, our total debt stands at about INR 555 crores, comprising of INR 474 crores in short-term debt and INR 81 crores in the long-term debt. Debt-to-equity ratio on a stand-alone basis stood at nearly 0.31. On a consolidated basis, our total debt stands at INR 732 crores, which includes INR 477 crores in the short-term debt and INR 256 crores in the long-term debt. Debt-to-equity ratio on a consolidated basis stood at 0.46. In quarter 1 FY '27, we have made a debt repayment of approximately INR 32 crores. So to conclude, despite of subdued demand environment during the quarter, our focus on optimizing the product mix, disciplined pricing strategy and continued efforts to enhance operational efficiencies enable us to deliver a healthy improvement in profitability. While near-term demand may continue to be influenced by the macroeconomic uncertainties, we remain confident in our long-term growth prospects given our state-of-the-art infrastructure, plant compatibility, diversified product portfolio and a strong geographic presence. With this, I hand over the call to the moderator to open the floor for questions and answers. Thank you.
Operator
operator[Operator Instructions] The first question is from the line of Rohit Sinha from Sunidhi Securities.
Rohit Sinha
analystCongratulations for good set of numbers. So some of the questions from the pigment side, basically, although we have seen good improvement in the profitability of pigment side, but the utilization remains quite low. So how -- as you have indicated on the PPT that it's because of the softer demand, how we are seeing the demand right now? And would there be any possibility that we'll see better utilization level in this, or it will remain more or less under 45, 50 kind of level?
Ankit Patel
executiveThank you, Rohitji. So for the -- particularly in the pigment segment, the utilization level might be in the more or less this range in terms of the percentage. From the overall revenue perspective, we -- whatever we believe -- we believe that we will be somewhere in the range of INR 550 crores to INR 600 crores on an annualized basis in the pigment segment. But there will be -- compared to previous years, we have been working on various things to improve our operational efficiencies, which was -- which we were doing since last 1 year. And a lot of improvements has taken place and -- which is helping in terms of better operational cost reduction and which is helping to improve overall profitability in the pigment segment.
Rohit Sinha
analystOkay. So I mean, just any thoughts on how this demand would be looking at in the Q2 or Q3 or 4, FY '27 per se, in the pigment side?
Ankit Patel
executiveAs I mentioned that overall, as a year point of view, we believe we'll be in the range of about INR 550 crores to INR 600 crores in top line revenue. Maybe on 1 or 2 quarters, there might be some macroeconomical factors might be impacting a little bit. But on a yearly basis, we are confident.
Gurjant Chahal
executiveJust to add, Rohit, because last year, pigment was adversely impacted by the tariff. So from 1st April, so now that hangover is over. So things have started improving. So it has started picking up.
Rohit Sinha
analystAnd secondly, on the Crop Protection side, as we had lower revenue in this quarter. So how -- again, here also, how we would be looking at the volumes going forward? And would there be a better realization or better product mix, which will lead us to better margins in this segment?
Ankit Patel
executiveSo Rohitji, as far as the Crop Protection segment is concerned, we are very optimistic from the growth perspective, be it this year or over a period of next 2 to 3 years' time because we have been investing heavily on new registrations, new product development and which is going to drive the growth of this segment. So maybe 1 or 2 quarters here and there, there might be some factors will be there because of the macroeconomical issues, which we all know. But on overall basis, we are very confident for the growth of this segment.
Rohit Sinha
analystOkay. Okay. Any number we can have on the volume growth or the margin side?
Ankit Patel
executiveSo as we have been telling that on the top line basis, we'll be growing in double digit in the Crop Protection segment. At the same time, we focus on the profitability as well. So year as a whole, when we compare, there will be a double-digit growth in top line, and there will be healthy improvement in bottom line as well.
Rohit Sinha
analystGot it. Got it. And sir, on the Nano Urea side, I think this quarter, we had some decent contribution from there. Would this be -- continue going forward? Or we see any improvement or how this number would be looking like?
Ankit Patel
executiveYes. So again, for the Crop Nutrition segment, where we have Nano Urea is one of the key products which we started with. We have added 3 more new Nano-based fertilizer, which is Nano DAP, Nano NPK, Nano Zinc, and we'll keep on adding other Nano-based fertilizers in the segment. So we are very optimistic for this segment as well. We have been doing developmental activity not only in India, but globally into different markets. In the few markets, we have started getting the orders, trial orders and the results are very good, very encouraging results are there in the market. So we are very optimistic from the growth point of view for the Crop Nutrition segment as well. So it will keep on showing the growth quarter-on-quarter basis along with the profit.
Operator
operatorThe next question is from the line of Harshit Singhania from RoboCapital.
Harshit Singhania
analystHello, am I audible?
Ankit Patel
executiveYes, Harshit, please.
Harshit Singhania
analystCongratulations on a great set of numbers, sir. I just wanted to -- like I'm new to the company. So I just wanted to clarify or ask a few things. So in the last call, I think we have said that our peak revenue for agrochem infra is INR 2,500 crores. For pigments, it is INR 700 crores to INR 750 crores. So just to get a clearer picture, in the agrochem infra, we are including the Nano Urea in this. Is that right?
Ankit Patel
executiveI'm sorry, Harshitji. We have not given such guidelines of INR 2,500 crore revenue for Crop Protection division and INR 750 crore guideline for Pigment division. We have not given such kind of guidelines. So that is incorrect. For the Crop Protection segment, we have been telling we'll be growing in double digit over a period of next 2 to 3 years' time. At the same time, we'll be maintaining the healthy profitability, which is the industry average is in the range of 15% to 17%. We will try to be in this range or maybe above this range for the Crop Protection segment. For the Pigment segment, demand or the growth will not be significantly heavy because it's a little less growth-oriented industry. Over there, we believe our revenue will be somewhere in the range of INR 500 crores to INR 600 crores. We are not doing any big CapEx in this segment. And we will try to improve the profitability compared to the previous years in the Pigment segment. For the Crop Nutrition segment, again, we have been adding a lot of new Nano-based fertilizers, a lot of new products. So far, the base of the revenue is very, very small, but we have a very optimistic view and the kind of the investment what we are doing in the developmental activity. We are very sure that it will drive a healthy growth for the company with a better profit.
Harshit Singhania
analystSo sir, at these current levels, then what would be our revenue generation at peak potential, like when we are at optimum utilization for all the segments?
Ankit Patel
executiveSo peak revenue -- so for this year, you are asking or overall, you are asking?
Harshit Singhania
analystNo, at optimum utilization. So if all the plants are at optimum utilization?
Ankit Patel
executiveSo still, there is a lot of gap. There can be much higher revenue for the agrochemical segment. In the Pigment segment, we ourselves are not doing the full utilization as the market is under pressure. So that is the case. So we believe on the better utilization, which is nearly 85% to 90% utilization for the Crop Protection segment, we can do the revenue in the range of INR 2,500 crores to INR 3,000 crores.
Harshit Singhania
analystOkay. And for the Pigments?
Ankit Patel
executiveFor the pigment, as I mentioned, we are running in the range of nearly 40% to 50% range, where we'll be generating the revenue close to INR 500 crores to INR 600 crores. We don't plan to increase our revenue by doing more utilization because the market is under pressure from the demand point of view, there is overcapacity. So we look at the profitability rather than top line for the Pigment segment.
Harshit Singhania
analystAnd sir, going forward in the year, can we expect similar margins to be maintained? Is this a sustainable level?
Ankit Patel
executiveAs I mentioned, for the Crop Protection segment, industry average is in the range of 15% to 17%. So we will try to be in that range or try to be above that range for the Crop Protection segment. For the Pigment segment, we were at very low level in terms of the EBITDA margin, where we have been trying to improve the EBITDA margin somewhere in the nearly 10% range or we'll try to be a little higher than that. This was one of the odd quarters, but we would like to improve the profitability.
Operator
operatorThe next question is from the line of Abhishek Jain from [ Cris ] PMS.
Unknown Analyst
analystCongrats for a strong set of numbers in tough times. Sir, my first question on the pigment side. As you mentioned that your total revenue to be around INR 600 crores in Pigment segment and you are looking for the margin of around 10%. So will it be sustained in the second half as well, when the prices will start to go down?
Ankit Patel
executiveSo Abhishekji, as I mentioned, we will try to maintain our revenue somewhere in the range of INR 500 crores to INR 600 crores. From the profitability point of view, we have been taking some corrective actions at the operational level, which is helping to improve our overall cost and improve the profitability. As far as the realization is concerned, which is based on the market conditions, there will be definitely pressure based on the raw material prices and the sales prices. But whatever corrective actions we have been taking, we will try to be somewhere near the 10% EBITDA margin range.
Unknown Analyst
analystOkay. And during this quarter, we have seen an expansion of margin from 3% to 12%. So what is the contribution of your operating efficiencies? And what is the contribution of your price increase in overall expansion in the EBITDA margin?
Ankit Patel
executiveYes. So yes, definitely, about 5% to 6% is because of the better realization and the balance is because of the better efficiency.
Unknown Analyst
analystAnd what is your expectation on the pricing front in the quarter 2 and the second half of FY '27?
Ankit Patel
executiveIt is very difficult to predict in current scenario where every day, we have been getting different news from the macroeconomic factor point of view. If it would have been a stable scenario, then we can predict it. But in current situation, it would be very difficult to predict. So we have been -- along with our team, we have always been taking the calls on a regular basis based on the prices, based on the market conditions. So it's a very volatile situation right now.
Unknown Analyst
analystGot it. And how is the current inventory position across distributors in Latin America, Europe and India? And has channel destocking completed? Or just we can go for the channel destocking in the coming quarter as well?
Ankit Patel
executiveSo the good thing, be it a Crop Protection division or be it a Pigment division, the good thing is there is not much inventory at the customer level or at the distributor level. So they have been buying the material on the spot basis based on their requirement. So it is not building the inventory, which is a very positive sign. And we have been seeing healthy demand in both the segments. The only factor is the macroeconomic factor, which is keeping everything volatile. Otherwise, from a demand point of view, there is a reasonably healthy demand.
Unknown Analyst
analystOkay. So that means once that the prices will start to go down and the logistic prices will start to correct, then we'll see the healthy demand of these products and restockings will start, right, sir?
Ankit Patel
executiveSo both the things. So the prices will go down along with the decreasing in the raw material prices. So if the raw material prices will go down, the sales price will go down. If it doesn't go down, then it will be more or less in this range.
Unknown Analyst
analystAnd my last question on the amalgamation of the few companies you are looking for, if you can throw some light over there.
Gurjant Chahal
executiveSo as per the scheme, so we have filed scheme in April, and then we had now a second motion application filed after getting approval from the secured and unsecured creditors. So now we are waiting for the next date of hearing from the NCLT.
Unknown Analyst
analystAnd after this amalgamation, what would be the impact on the top line EBITDA and the PAT of the company? Is it EPS accretive or what is it?
Gurjant Chahal
executiveThis is the amalgamation of the 2 wholly owned subsidiaries. So whatever the consolidated financials you are looking, so it will be continuing that way. And this amalgamation, the accounting treatment will be pulling of interest method where every line item will get added to the MOL. So from the EBITDA business as usual, it will be continuing. So -- but it will be from the various synergies, which will be coming from the cost reduction or you can say, smooth operations. So those benefits definitely going to come.
Unknown Analyst
analystHow much impact on the margin because of this?
Gurjant Chahal
executiveMargin from the business perspective, it may be more from a cost reduction. So for example, in the multiple, you can say, stock points, which we have, so it will not be there. So we have to close. So those type of costs will be down. So that will improve from the cost point of view and the compliance point of view.
Ankit Patel
executiveSo it will bring more discipline to the operations.
Operator
operator[Operator Instructions] The next question is from the line of Nipun Sharma from VLS Finance.
Nipun Sharma
analystAm I audible?
Ankit Patel
executiveYes, Nipunji.
Nipun Sharma
analystSo congratulations on a good set of results. My first question is regarding Nano Urea. So in the last quarterly con call, when we had a conversation, you said that you are planning to expand the basket of Nano Urea for the future. So first of all, how is that going? And second of all, how much Nano Urea sales happened in this quarter?
Ankit Patel
executiveSo Nipunji, as we have informed, we have been expanding the basket for -- in this segment. We have got 3 new products in the basket now apart from Nano Urea. We have got Nano DAP, Nano NPK and Nano Zinc. So these are the 3 products which we have added, and we are in the process of getting approval in the different markets to expand this product sales as well. Gradually, the sales of Nano Urea is picking up well in domestic market as well as in the global market, wherever we have been getting the registration. So far, I think from the volume perspective, we cannot disclose the volume for the Nano Urea point of view, but there has been relatively healthy growth.
Nipun Sharma
analystOkay. Good to hear. And any idea -- I mean, any guidance on how much this will contribute in the future? I mean, how much significantly this Nano Urea will contribute in the future?
Ankit Patel
executiveSo from the future perspective, we have a very, very optimistic plan for this segment, Nano fertilizer. So there will be a couple of hundred crore revenue coming from this segment over a period of next 2 to 3 years' time.
Nipun Sharma
analystOkay. Good to hear. And my second question is on pigment. I mean, congratulations on having a good profitability for pigment. And my question was that is this profitability and the revenue from pigment sustainable for the upcoming quarters? I mean, can we consider this as a quarterly run rate for FY '27 and the following financial years?
Ankit Patel
executiveSo yes, Nipunji, as far as the top line for the Pigment segment is concerned, it will be more or less in this range on a quarter-on-quarter basis. And as far as the profitability is concerned, this quarter was a little higher side. We would always try to be in this range, but it is a little more optimistic. But somewhere down the line, we would prefer to be near 10% EBITDA margin range for Pigment segment.
Nipun Sharma
analystAnd for revenue, this much amount as a quarterly run rate. Can we consider this as an estimate for FY '27?
Ankit Patel
executiveYes.
Operator
operatorThe next question is from the line of Love Gupta from Counter Cyclical Investments.
Love Gupta
analystSo firstly, I just wanted to understand one of our peers, Kesar Petroproducts is able to convert byproducts or waste products of CPC blue pigments to fertilizers. So do they have like a process know-how advantage over us? Or what's stopping us from selling byproducts like zinc phosphate or zinc sulfate?
Ankit Patel
executiveSo Guptaji, we also convert some of our products into fertilizer. So product to product, it differs. We also have a fertilizer as a byproduct in our Pigment segment. And we have been doing this since many, many years, and we have been selling it.
Love Gupta
analystOkay. Great. And sir, second question was, given the inflationary raw material environment, are we seeing any consolidation happening across the pigment industry?
Ankit Patel
executiveSo far, there has been reduction in the capacity utilization at different companies' level because of the higher cost and lower demand. So some of the companies have reduced their capacity, which helps in maintaining the balanced supply/demand, which is also helping a little bit to us. As far as the consolidation is concerned, because this industry is a little stagnant industry, I would say. So people are not going for consolidation or merger acquisitions.
Operator
operatorThe next follow-up question is from the line of Abhishek Jain from Cris PMS.
Unknown Analyst
analystSir, my next question on the titanium dioxide. So in the titanium oxide, basically, your plant will be suspended because of the higher raw material prices. So just wanted to understand how much EBITDA you are losing because of this plant is at a closing stage right now.
Ankit Patel
executiveSo I'm sorry, Abhishekji, you mentioned how much EBITDA we are...
Unknown Analyst
analystLosing because of this -- suspended your production at this point.
Ankit Patel
executiveOkay. Okay. Okay. Just a minute. So for the Kilburn Chemical, which is titanium dioxide segment, in the first quarter, we had a negative EBITDA of nearly INR 3 crores.
Unknown Analyst
analystNearly INR 3 crores. So overall losses would be at INR 10 crores to INR 12 crores on annual basis if this plant will be -- continue to be suspended this year.
Ankit Patel
executiveYes, that's correct. So because we have kept the operation suspended, so there has been a substantial reduction in the loss.
Unknown Analyst
analystOkay. So annual basis, you would be able to make a consolidated margin of 15% to 16% on the INR 2,600 crores kind of the revenue what you are targeting?
Ankit Patel
executiveSee, 15% to 16% margin on an overall basis is very much high because somewhere for the agrochemical segment, we -- as we mentioned, we will try to be in the industry average, which is 15% to 17%. In the Pigment segment, it would be somewhere in the 10%. So overall, we believe we will be in the range of about 12% to 13%.
Unknown Analyst
analystOkay. So if I'm taking that 16% margin of your Crop Protection business and 10% margin of this Pigment business and this INR 10 crores, then my margin calculation is coming around 15%, 16%. That's why I was asking.
Ankit Patel
executiveYes. But at the same time, on a consolidated basis, there will be effect from the other segment realization.
Unknown Analyst
analystOkay. And how much savings would be possible from the debt repayment?
Ankit Patel
executiveFrom what?
Unknown Analyst
analystInterest cost saving because of the debt repayment because this quarter, the interest cost has gone down.
Gurjant Chahal
executiveSo on yearly repayment, we have around INR 130 crores this year, and our average debt cost is around 7%. So to that extent, it is going to be a saving in the finance cost.
Operator
operator[Operator Instructions] The next question is from the line of N. M. Modi, an individual investor.
Unknown Attendee
attendeeI've joined late, sir. Maybe I am repeating the question. My question is regarding, sir, finance cost. There is substantial reduction in the finance cost. So what has contributed that? And is it going to be the case?
Gurjant Chahal
executiveYes. So there are 2 reasons to it. Actually, if you have seen the last year, there was a lot of volatility into the foreign currency. So we have started taking debt into the INR, while the INR cost rate of interest were lower. And that is one reason. MTM loss is not there. In the previous quarter as well as the last year, there was a MTM due to foreign currency. And second is the debt reduction, which is now getting repaid. So to that extent, it is also a reduction into the finance cost. So these are the 2 reasons.
Unknown Attendee
attendeeSo we can say that this will be the trend going forward?
Gurjant Chahal
executiveYes. Going forward, impact of MTM is going to be minimal.
Ankit Patel
executiveAt the same time, there will be continuous repayment because we are not going to do heavy CapEx for next 1 or 2 years' time. So as we are growing in terms of top line and bottom line, we'll be continuously reducing the debt.
Operator
operatorThe next question is from the line of Mohit from Subh Lab Research.
Mohit Chugh
analystHope I am audible?
Ankit Patel
executiveYes, we can hear you.
Mohit Chugh
analystSir, my first question is our revenue has declined by around 12% Y-o-Y during this quarter. So if you can just give a ballpark number, how much of revenue degrowth was attributable to lower volumes versus pricing?
Ankit Patel
executiveI'm sorry, can you repeat your question?
Mohit Chugh
analystSir, the 12% degrowth that we have seen this quarter Y-o-Y. So how much was attributable to volume degrowth and pricing growth, if you can bifurcate between volume and pricing?
Ankit Patel
executiveJust a minute, just a minute. So as far as the volume degrowth is concerned -- so there has been reduction by nearly 17% volume reduction.
Mohit Chugh
analystOkay, sir. And can we assume that there was 5% realization growth? Or was there any...
Ankit Patel
executiveTypically, what we did, Mohitji, because the market was more volatile, we were focusing more on the profitability and bottom line. So we keep on playing with the different product mix where we have a better profitability. And that's what the focus area was. And that has helped, though there has been reduction in the top line, there has been improvement in the profitability. So as a company, definitely, the top line growth is important. But at the same time, as a management, we look at more from the bottom line point of view.
Mohit Chugh
analystGot it, sir. This was very helpful, sir. Sir, my follow-up on this is, could you please help us understand which geographies contributed to most decline?
Ankit Patel
executiveIt was more from the Latin America.
Mohit Chugh
analystOkay. So are we facing any competitive pressure there? Or it was just due to weather and the demand there that was -- that led in volume degrowth?
Ankit Patel
executiveSo basically, demand is there slowly gradually, but there was a pressure from the pricing point of view because of the global macro factor, there was an increase in the input cost. And we always prefer to pass it on to our customer. And if there is any resistance to that, then we don't push too much to maintain our top line or increase our top line. We focus on the bottom line rather than that. So we prefer selling the product in the market where we have a better realization or we prefer selling the product, which has got better realization.
Mohit Chugh
analystGot it, sir. This is very helpful. And if you can give any outlook for the 9 months coming, like would we be seeing the improvement going ahead?
Ankit Patel
executiveSo Mohitji, we are very optimistic. So maybe this is one of the quarters -- 1 or 2 quarters might be a little difficult. But on the overall as a year basis or looking at next 2 years, 3 years' time line, we are very optimistic for the company, for particularly Crop Protection and Crop Nutrition segment, there will be a very healthy growth in top line and bottom line, where the Pigment segment will be relatively stable in top line, and we'll try to maintain better profitability.
Operator
operatorThe next question is from the line of [ Nachiket Kale ] from Emkay.
Unknown Analyst
analystCongrats on the good result. My query was actually on the finance cost, which just got answered. I just wanted to know going forward, as you have mentioned before, Crop Protection is going to grow a lot. But on the Pigment side, could you give some forward-looking guidance?
Ankit Patel
executiveSo as I mentioned, the Pigment side, again, our focus is more on the profitability. So we don't want to just increase our top line and compromise on the bottom line. We would rather maintain the healthy top line with a better profitability. That is what the...
Unknown Analyst
analystRight. So the trend we have seen in Q1 can be maintained in pigments going forward?
Ankit Patel
executiveSo the top line point of view can be maintained in Pigment segment, and the bottom line point of view, there might be a little plus or minus. But on an overall basis, we'll try to maintain about nearly 10% EBITDA.
Operator
operator[Operator Instructions] The next question is from the line of Ansh Sharma, an individual investor.
Unknown Attendee
attendeeCan you hear me?
Ankit Patel
executiveYes, I can hear you, Anshji.
Unknown Attendee
attendeeSir, I just wanted to know about titanium dioxide. What is that you're looking forward for? As we have closed the operations, is there any communication from the industry or from the government? And what is that we can expect in coming time, coming quarters, if you could rather say?
Ankit Patel
executiveSo to be very frank, because the key raw material prices are -- has gone up extremely, extremely high, which we have never seen in the past, which is out of anyone's control. And as far as the antidumping is concerned, we have been pursuing with the government department. But you might be knowing in the recent time because of the macro factor war situation, government even abolished the basic customs duty on various chemicals to support the domestic market and the domestic industry. So for the time being, there has not been any improvement as far as the antidumping is concerned. So we are waiting for -- from the 2 factors point of view, one is the raw material prices getting normalized at the same time, the antidumping duty getting back on track. So till the time, we have decided to keep the operation suspended.
Unknown Attendee
attendeeSo there is no time line or whatsoever for this until unless the things improve? Or is there any guidelines or anything as such?
Ankit Patel
executiveTo be very frank, from the raw material perspective, if I give you the idea, let's say, the sulfur, which is the basic raw material, which is getting converted into sulfuric acid, which is a key raw material for the titanium dioxide. The normal price for this product used to be -- for this raw material used to be in the range of INR 4 to INR 5. It has gone to nearly in the range of INR 35 to INR 40. So there has been almost 8 to 10x increase in the raw material price, which we have never seen in the past. So it is beyond anyone's imagined and control.
Unknown Attendee
attendeeAnd this is only for the domestic, sir, or even the international market, the prices has gone up for the raw material, as you have said?
Ankit Patel
executiveSo overall sulfur is a global commodity. I would say more than 80% of the sulfur is coming from the Middle Eastern region, which is impacted because of the war condition and which has drived the sulfur price significantly high. So it is a global phenomenon. And the sulfuric acid price based on that, it is coming from sulfur as well as from some of the metal industry as a byproduct from copper and zinc. So depending on the market, sulfuric acid price varies, but it has also gone up significantly in the global market.
Unknown Attendee
attendeeThank you so much for the guidance, and I hope company continues to perform well.
Operator
operatorLadies and gentlemen, that was the last question. I would now like to hand the conference over to the management for closing comments.
Ankit Patel
executiveOn behalf of the management, we thank you for joining us today. We appreciate your trust and support on us. With this, we hope that we have been able to address most of your queries. In case of further queries, you may reach out to Mr. G.S. Chahal, Mr. Nishant Vyas, and we will connect with you offline. Thank you.
Operator
operatorOn behalf of Arihant Capital Markets, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Meghmani Organics Limited transcript — plus 252,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Meghmani Organics Limited earnings transcripts and 252,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.